97 related articles for article (PubMed ID: 3274440)
1. The effect of cyclosporine A in cadaver donor retransplants: a surprising effect of the sex of the donor.
Cecka JM; Cicciarelli J; Terasaki PI
Transplant Proc; 1987 Feb; 19(1 Pt 3):1842-4. PubMed ID: 3274440
[No Abstract] [Full Text] [Related]
2. Long-term impact of HLA matching on kidney graft survival in cyclosporine-treated recipients.
Opelz G; Schwarz V; Engelmann A; Back D; Wilk M; Keppel E
Transplant Proc; 1991 Feb; 23(1 Pt 1):373-5. PubMed ID: 1990556
[No Abstract] [Full Text] [Related]
3. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
[TBL] [Abstract][Full Text] [Related]
4. Effect of DR and DR6 matching on cadaver kidney transplant survival.
Reyman TA; Toledo-Pereyra LH
Transplant Proc; 1987 Feb; 19(1 Pt 1):702-4. PubMed ID: 3274848
[No Abstract] [Full Text] [Related]
5. The results of renal transplantation with cyclosporine in immunologically high-risk patients.
Dickerman RM; Vergne-Marini P; Langley J; Trevino G; Velez R; Brinker K; Nesser D; Long D; Hull AR
Transplant Proc; 1987 Feb; 19(1 Pt 3):1846-8. PubMed ID: 3079047
[No Abstract] [Full Text] [Related]
6. Cadaveric renal transplantation after pulsatile perfusion, histocompatibility matching, and conversion to cyclosporine therapy.
Milgrom M; Kyriakides GK; Esquenazi V; Olson L; Miller J
Transplant Proc; 1987 Feb; 19(1 Pt 3):1873. PubMed ID: 3274444
[No Abstract] [Full Text] [Related]
7. Is cyclosporine a match for tissue typing centers? Role of the zero HLA-A, B, and DR mismatch effect.
Cicciarelli J; Terasaki PI; Cecka M; Mickey MR
Transplant Proc; 1987 Feb; 19(1 Pt 1):647-9. PubMed ID: 3274831
[No Abstract] [Full Text] [Related]
8. Local use of kidneys with poor HLA matches is as good as shared use with good matches in the cyclosporine era: an analysis at one and two years.
Alexander JW; Vaughn WK; Pfaff WW
Transplant Proc; 1987 Feb; 19(1 Pt 1):672-4. PubMed ID: 3274836
[No Abstract] [Full Text] [Related]
9. The impact of cyclosporine A on the DRw6 effect in renal transplantation.
Hendriks GF; de Lange P; Schreuder GM; D'Amaro J; Persijn GG; van Rood JJ
Transplant Proc; 1987 Feb; 19(1 Pt 1):650-1. PubMed ID: 3274832
[No Abstract] [Full Text] [Related]
10. Kidney retransplantation in the cyclosporine era.
Stratta RJ; Oh CS; Sollinger HW; Pirsch JD; Kalayoglu M; Belzer FO
Transplantation; 1988 Jan; 45(1):40-5. PubMed ID: 3276060
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine therapy and other adjuncts in the perioperative period with cadaveric and living related donor kidney transplantation.
Milgrom M; Esquenazi V; Olson L; Fuller L; Roth D; Condie R; Kyriakides G; Miller J
Transplant Proc; 1986 Apr; 18(2 Suppl 1):8-11. PubMed ID: 3515699
[No Abstract] [Full Text] [Related]
12. The HLA-matching effect in different cohorts of kidney transplant recipients.
Terasaki PI
Clin Transpl; 2000; ():497-514. PubMed ID: 11512361
[TBL] [Abstract][Full Text] [Related]
13. HLA-DR1 recipients have the highest kidney transplant survival.
Cook DJ; Cecka JM; Terasaki PI
Transplant Proc; 1987 Feb; 19(1 Pt 1):675-7. PubMed ID: 3274837
[No Abstract] [Full Text] [Related]
14. The effects of donor specific transfusion and cyclosporine A on graft outcome.
Haberal M; Oner Z; Aybasti N; Arslan G; Turan M; Bilgin N
Transplant Proc; 1987 Feb; 19(1 Pt 3):2269-70. PubMed ID: 3274506
[No Abstract] [Full Text] [Related]
15. Twenty-year follow-up on the effect of HLA matching on kidney transplant survival and prediction of future twenty-year survival.
Terasaki PI; Cho Y; Takemoto S; Cecka M; Gjertson D
Transplant Proc; 1996 Jun; 28(3):1144-5. PubMed ID: 8658601
[TBL] [Abstract][Full Text] [Related]
16. Renal allograft survival in highly sensitized patients treated with cyclosporine.
Doran M; Coppage M; Ruth J; Fish J; Winsett O; Vaidya S
Transplant Proc; 1987 Feb; 19(1 Pt 3):1988. PubMed ID: 3274458
[No Abstract] [Full Text] [Related]
17. Cyclosporine: its time of impact on kidney graft survival.
Gilks WR; Bradley BA; Gore SM
Transplant Proc; 1990 Oct; 22(5):2282. PubMed ID: 2219368
[No Abstract] [Full Text] [Related]
18. Influence of HLA matching on kidney allograft survival.
Suciu-Foca N; Cohen DJ; Benvenisty AI; Benstein JA; Reed EF; Ho E; Hardy MA
Transplant Proc; 1996 Feb; 28(1):121-2. PubMed ID: 8644140
[No Abstract] [Full Text] [Related]
19. Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy.
Giral M; Taddei C; Nguyen JM; Dantal J; Hourmant M; Cantarovich D; Blancho G; Ancelet D; Soulillou JP
Clin Transpl; 1996; ():257-64. PubMed ID: 9286575
[TBL] [Abstract][Full Text] [Related]
20. Randomized clinical trial of cyclosporine or donor specific transfusions in high risk living-related donor transplantation.
Bordes-Aznar J; Odor A; Dib-Kuri A; Gabilondo F; Kasep J; Peña JC; Herrera-Acosta J; Chávez-Peón F
Transplant Proc; 1987 Feb; 19(1 Pt 3):2276-7. PubMed ID: 3079080
[No Abstract] [Full Text] [Related]
[Next] [New Search]
